Previous 10 | Next 10 |
SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Zynex, Inc. (NASDAQ: ZYXI) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/ZYXI Contact An Attorney Now: ZYXI@hbsslaw.com 844-916-0...
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI ). The investigation concerns whether Zynex and/or certain of its officers have v...
ATLANTA, March 08, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) complied with federal securities laws. On March 6, 2023, Zynex announced it was postponing “the release of ...
2023-03-07 12:39:41 ET Gainers: ThredUp ( TDUP ) +73% . WW International ( WW ) +49% . Unicycive ( UNCY ) +39% . Protagonist Therapeutics ( PTGX ) +32% . Bionomics ( BNOX ) +28% . Novo Integrated Sciences ( NVOS ) +25% ...
2023-03-07 11:28:43 ET Gainers: Unicycive ( UNCY ) +52% . Bionomics ( BNOX ) +49% . Novo Integrated Sciences ( NVOS ) +37% . Protagonist Therapeutics ( PTGX ) +34% . Allakos ( ALLK ) +22% . Losers: Cara ( CARA ) -28...
2023-03-07 06:37:19 ET Medical device maker Zynex ( NASDAQ: ZYXI ) shed ~7% pre-market Tuesday due to an abrupt decision to delay the release of its Q4 and full-year financials and a conference call, initially scheduled for Mar. 06 after the close. Zynex ( ZYXI ) d...
2023-03-06 17:01:40 ET Gainers: ATA Creativity ( AACG ) +17% . WW International ( WW ) +7% . bluebird bio ( BLUE ) +3% . TuSimple Holdings ( TSP ) +3% . ACADIA Pharmaceuticals ( ACAD ) +3% . Losers: Cara...
Zynex, Inc. to Postpone Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call PR Newswire ENGLEWOOD, Colo. , March 6, 2023 /PRNewswire/ -- Zynex, Inc . ( Nasdaq: ZYXI ) , an innovative medical technology company specializing ...
2023-03-05 17:35:14 ET Major earnings expected after the bell on Monday include: Nutanix ( NTNX ) Cara Therapeutics ( CARA ) Trip.com Group Limited ( TCOM ) AeroVironment ( AVAV ) Intrepid Potash ( IPI ) For further details see: Notable ea...
2023-03-05 17:35:00 ET Zynex ( NASDAQ: ZYXI ) is scheduled to announce Q4 earnings results on Monday, March 6th, after market close. The consensus EPS Estimate is $0.18 (-21.7% Y/Y) and the consensus Revenue Estimate is $49.72M (+23.2% Y/Y). Over the la...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...